General fatigue after taking tenofovir alafenamide tablets/Veride for one year

Tenofovir alafenamide fumarate tablets/Veride (TAF) has been used to treat chronic hepatitis B since its approval. It is an option for adults andchildren 6 years and older. Hepatitis B virus is usually spread through body fluids such as blood or sperm. They attack the liver, where they can cause an acute inflammation called hepatitis. In many cases, the condition causes no symptoms and goes undetected. Tenofovir alafenamide tablets are designed to prevent viral reproduction. Patients who receive treatment and have the virus permanently undetectable in their blood are thought to be at lower risk of developing such complications.

It has been reported that some patients taking tenofovir alafenamide fumarate tablets to treat hepatitis B may develop symptoms of general fatigue after long-term use. Generalized malaise is a state in which the entire body feels tired, weak, and lacking in energy. This symptom can have a negative impact on the patient's quality of life and daily functioning. Tenofovir alafenamide fumarate tablets may impose a certain burden on the body, leading to increased fatigue; it may also interfere with the body's metabolic process, affecting the normal production and utilization of energy, resulting in general fatigue. But everyone's response to and tolerance of medications is different. One year of use may cause some side effects, and malaise may be one of them.

If the patient is taking tenofovir alafenamide fumarate tablets and develops symptoms of general fatigue, it is recommended to consult a doctor in time. Your doctor will evaluate your symptoms and may order tests to determine the cause of your fatigue. During this process, make sure to provide the doctor with a detailed medical history and medication usage to help the doctor make a correct diagnosis and develop an appropriate treatment plan.